Moderate-to-Severe Psoriasis and Psoriatic Arthritis: Reducing the Clinical and Economic Burden Through Effective Treatment Protocols

On-Demand Slide Lecture with Audio

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters/Q&A Cohost

Jeffrey M. Weinberg, MD
Director, Clinical Research Center
St. Luke’s-Roosevelt Hospital Center
Assistant Clinical Professor of Dermatology
Columbia University
New York, New York

John A. Goldman, MD, FACR, FACP, CCD
Chief of Rheumatology
St. Joseph’s Hospital
President, Medical Quarters
Medical Director, Atlanta Center for Clinical Research
Atlanta, Georgia

David Calabrese, RPh, MHP
Chief Clinical Officer
MedMetrics Health Partners
Assistant Clinical Professor
Northeastern University Bouvé College of Pharmacy
Boston, Massachusetts

Target Audience

This activity is designed for managed markets physicians and pharmacists and case managers.

Learning Objectives

After completing this activity, participants should be able to:

Describe the clinical and economic burden of moderate-to-severe psoriasis and psoriatic arthritis
Implement treatment protocols that incorporate therapeutic efficacy measures and foster communication between specialists and other providers to ensure effective diagnosis and management of moderate-to-severe psoriasis and psoriatic arthritis
Outline the benefits and limitations of biologic therapies for moderate-to-severe psoriasis and psoriatic arthritis, including dosing regimens, routes of administration, and adverse effect profiles
Incorporate biologic therapies into evidence-based treatment algorithms for moderate-to-severe psoriasis and psoriatic arthritis

Activity Overview

This on-demand slide lecture is available with html slides and the presentation transcript and a Q&A session transcript.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

This educational activity is a knowledge-based activity.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this activity.

Release Date: March 12, 2009

Expiration Date: March 12, 2010

Estimated time to complete: 1 hour

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-08-027-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

Case Manager Accreditation

This activity is approved for 1 hour of continuing education credit for case managers by the Commission for Case Manager Certification (CCMC).

Independent Clinical Reviewer: Abrar A. Qureshi, MD, MPH, Associate Physician, Co-Director, Center for Skin and Related Musculoskeletal Diseases (SARM), Brigham and Women's Hospital, Department of Dermatology, Boston, Massachusetts

Planning Committee

The planning committee comprises John A. Goldman, MD, FACR, FACP, CCD, Abrar A. Qureshi, MD, MPH, and Jeffrey M. Weinberg, MD; and Mary Johnson, Stacey Ohana, John Savage, and Randy Robbin, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Goldman: Grant/research support—Atlanta Center for Clinical Research; Promotional speakers bureau—Amgen, Biogen, Genentech, Lilly, Novartis, Pfizer, Roche, Wyeth; Share stockholder—Bristol-Myers Squibb
Dr. Qureshi: Consultant—Abbott, Amgen, Genentech; Promotional speakers bureau—Abbott, Amgen, Genentech
Dr. Weinberg: Grant/research support—Abbott, Amgen, Centocor Inc, Genentech; Consultant—Genentech; Promotional speakers bureau—Abbott, Amgen, Centocor, Inc, Genentech
Mr. Calabrese has disclosed no relevant financial relationships with any commercial interests.

Ms. Johnson, Ms. Ohana, Mr. Robbin, and Mr. Savage have disclosed that they have no relevant financial relationships with any commercial interest.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Centocor, Inc